• Thumbnail for Bosutinib
    Bosutinib, sold under the brand name Bosulif, is a small molecule BCR-ABL and src tyrosine kinase inhibitor used for the treatment of chronic myelogenous...
    10 KB (633 words) - 12:29, 5 August 2024
  • Bosutinib's activity was first described in 2001 and it was disclosed as an Abl kinase inhibitor in 2003. At first it was believed that bosutinib was...
    56 KB (6,475 words) - 07:21, 26 August 2024
  • Thumbnail for Chronic myelogenous leukemia
    approved in South Korea for people resistant to or intolerant of imatinib. Bosutinib received US FDA and EU European Medicines Agency approval on 4 September...
    34 KB (3,877 words) - 01:25, 22 July 2024
  • (ALK) Non-receptor bcr-abl Asciminib Bosutinib Dasatinib Imatinib Nilotinib Ponatinib Radotinib Src (Bosutinib Dasatinib) Janus kinase Baricitinib Fedratinib...
    12 KB (794 words) - 03:30, 2 September 2024
  • Thumbnail for Tyrosine kinase
    available inhibitors to treat CML are imatinib, dasatinib, nilotinib, bosutinib and ponatinib. Gastrointestinal stromal tumors (GIST) are known to withstand...
    43 KB (5,251 words) - 10:44, 24 June 2024
  • Thumbnail for Targeted therapy
    Sunitinib (Sutent) Dasatinib (Sprycel) Lapatinib (Tykerb) Nilotinib (Tasigna) Bosutinib (Bosulif) Ponatinib (Iclusig) Asciminib (Scemblix) Bortezomib (Velcade)...
    20 KB (2,234 words) - 01:21, 22 July 2024
  • (ALK) Non-receptor bcr-abl Asciminib Bosutinib Dasatinib Imatinib Nilotinib Ponatinib Radotinib Src (Bosutinib Dasatinib) Janus kinase Baricitinib Fedratinib...
    12 KB (758 words) - 23:46, 14 March 2024
  • Pharmaceuticals) Borofax bortezomib (USAN) Bosatria (GlaxoSmithKline) bosentan (INN) bosutinib (USAN, INN) botiacrine (INN) Botox (Allergan) Boudreaux's Butt Paste (Blairex...
    8 KB (401 words) - 04:48, 5 August 2024
  • Thumbnail for Pfizer
    injectables such as the EpiPen. On September 4, 2012, the FDA approved bosutinib (Bosulif) for chronic myelogenous leukemia (CML), a rare type of leukemia...
    167 KB (14,521 words) - 00:40, 7 September 2024
  • Thumbnail for Asciminib
    for "Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs" at ClinicalTrials.gov Portal:...
    17 KB (1,263 words) - 09:31, 30 July 2024